<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651530</url>
  </required_header>
  <id_info>
    <org_study_id>876543</org_study_id>
    <nct_id>NCT04651530</nct_id>
  </id_info>
  <brief_title>Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma</brief_title>
  <acronym>ECPNTG</acronym>
  <official_title>Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess whether endoscopic cyclophotocoagulation added to&#xD;
      cataract surgery lowers intraocular pressure more than cataract surgery alone in patients&#xD;
      with normal tension glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with normal tension glaucoma that is stable with current medication needing cataract&#xD;
      surgery are recruited in the study. All patients meeting the inclusion criteria and giving&#xD;
      informed consent will be randomized to whether having endoscopic cyclophotocoagulation&#xD;
      performed in the same session with cataract surgery, or cataract surgery alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Succes rate</measure>
    <time_frame>One year postoperatively</time_frame>
    <description>Success: Decrease in Intraocular Pressure (IOP) of 20 % or more or former level with fewer medications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional surgery</measure>
    <time_frame>Five years postoperatively</time_frame>
    <description>Comparison of the need for additional glaucoma surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Normal Tension Glaucoma</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Phaco</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cataract surgery only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phaco+ECP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cataract surgery combined with endoscopic cyclophotocoagulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phaco</intervention_name>
    <description>phacoemulsification of cataract only</description>
    <arm_group_label>Phaco</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phaco+ECP</intervention_name>
    <description>Endoscopic cyclophotocoagulation is done in the same procedure as phacoemulsification of cataract</description>
    <arm_group_label>Phaco+ECP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
          -  Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs&#xD;
             and/or optical coherence tomography (OCT) and possible equivalent visual field&#xD;
             defects, IOP never more than 21 mmHg, and open anterior chamber angle&#xD;
&#xD;
          -  Glaucoma stable with current medication assessed by a glaucoma specialist&#xD;
&#xD;
          -  Clinically significant cataract&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Secondary Glaucoma e.g. due to previous injury or uveitis&#xD;
&#xD;
          -  Exfoliation syndrome&#xD;
&#xD;
          -  Pigment dispersion syndrome&#xD;
&#xD;
          -  Previous transscleral or endoscopic cyclophotocoagulation&#xD;
&#xD;
          -  Previous other glaucoma surgery&#xD;
&#xD;
          -  Cataract due to eye injury or congenital cataract&#xD;
&#xD;
          -  Zonular weakness due to Marfan syndrome or other&#xD;
&#xD;
          -  Previous retinal detachment&#xD;
&#xD;
          -  Previous intraocular surgery like vitrectomy and other retinal surgery&#xD;
&#xD;
          -  Wet age-related macular degeneration&#xD;
&#xD;
          -  Diabetic retonopathy&#xD;
&#xD;
          -  Previous corneal transplant or previous refractive surgery&#xD;
&#xD;
          -  Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars&#xD;
&#xD;
          -  The patient does not want to participate in the study&#xD;
&#xD;
          -  The glaucoma progresses on current IOP&#xD;
&#xD;
          -  The patient does not speak Finnish, Swedish or English&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Only eye with vision worse than 20/200 or loss of central visual field&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mika Harju, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nina M Lindbohm, MD, PhD</last_name>
    <phone>+358505715668</phone>
    <email>nina.lindbohm@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jukka AO Moilanen, MD, PhD</last_name>
      <phone>+358405820860</phone>
      <email>jukka.moilanen@hus.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 26, 2020</study_first_submitted>
  <study_first_submitted_qc>November 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Prof. Mika Harju</investigator_full_name>
    <investigator_title>Head of Glaucoma department</investigator_title>
  </responsible_party>
  <keyword>endoscopic cyclophotocoagulation</keyword>
  <keyword>ECP</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Low Tension Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

